Podcast: Download (Duration: 2:12 — 3.5MB) | Embed

Subscribe: Apple Podcasts | Spotify | RSS

REGEN-COV is a monoclonal antibody cocktail of 2 drugs (casirivimab and imdevimab) that has been granted an Emergency Use Authorization by the FDA and is an important option in treatment to reduce the impact of COVID-19 in certain high-risk patients.

Resources:

https://www.eurekalert.org/news-releases/926467

https://combatcovid.hhs.gov/i-have-covid-19-now/monoclonal-antibodies-high-risk-covid-19-positive-patients

https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-regen-cov-monoclonal-antibody-therapy-post-exposure-prophylaxis-prevention-covid-19

https://www.regencov.com/

Related Episodes

• • Health & Wellness
  • Medical
  • Pharmaceuticals

  Y Chromosome Loss and Men’s Health                
• • For Families
  • Health & Wellness
  • Medical

  Prediabetes in Young Adults and Higher Heart Attack Risk